News and Announcements
Sold! Another License Taken In The US!
- Published July 16, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
In breaking news, a second Surf Lakes license has been sold in the US. While the location is to remain secret for the short term, there is genuine excitement as early design previews of the intended development look amazing! An announcement revealing more details will be forthcoming.
Despite the downturn in the global economy, due to COVID-19, this sale clearly demonstrates the continuing demand for positive infrastructure projects which will help to kick start local communities via creating jobs as well as future tourist attractions.
Every day the Surf Lakes team has been sifting through multiple enquiries, and at present, there are well over 500 enquiries from around the world.
With a definitive construction schedule across numerous projects including the Gold Coast and the potential upgrade to Yeppoon on the local front, the second half of 2020 is looking very promising!
About Surf Lakes Holdings Ltd
Surf Lakes 5 Wave technology is the world’s first multi-break surf park, where 5 different levels of waves are created simultaneously. This allows for surfers of all abilities to surf during the same session, something no other wave pool tech is capable of. And with up to 2,400 waves per hour, operators can maximise their return on capital, as well as generate revenue from corporate groups, competitions, events and more. The possibilities are endless!
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
